Oncology Case Log Examples
Case log #: 11 Date: 2/14/13 Patient ID: Callie
Species/Breed: canine/golden retriever Age: 9yr. Sex: FS Wt. 26.0 kg/57.2lb/0.88 m2
Diagnosis: splenic hemangiosarcoma stage 2
Advanced Skills & Procedures I performed: collected blood from left jugular vein for in house CBC/chemistry (HCT 28.9%, thrombocytosis 760,000). Using ultrasound guidance collected urine via cystocentesis for sterile urinalysis. Aseptically prepped skin and placed 22 gauge peripheral IV catheter in right cephalic vein. Administered dexrazoxane (Zinecard® 100mg/ml, 300mg/m2= 264mg/26.4ml) diluted with equal amount 0.9%NaCl, over 10 minutes. Dexrazoxane (Zinecard®) was used for this patient because post operatively (after splenectomy) she struggled with arrhythmia, and because of recommendation of cardiologist. Using the class II laminar safety hood, Phaseal® system, and full PPE (gown, gloves, goggles, mask) - drew up and attached extension set to t-port and then administered dolasetron (20mg/ml, 0.6mg/kg: 15.6mg/0.78ml) IV, followed by doxorubicin (2mg/ml, 30 mg/m2=26.4mg/13.2ml) diluted with 14ml of 0.9% NaCl in a 35ml syringe over 27 minutes, using PhaSeal® attachments. After chemotherapy transfusion finished flushed line with 15mls of 0.9% NaCl and removed IV catheter. Placed bandage over injection site. Filled out patient’s flow sheet and recorded charges.
Advanced Skills & Procedures I assisted with: calculated dolasetron, dexrazoxone, doxorubicin, mediation refills (maropitant, metronidazole)
Outcome: patient had two doses of dexrazoxone/doxorubicin chemotherapy and restaged via ultrasound. Liver nodules seen, but owner elected not to aspirate, but to continue with carboplatin chemotherapy. After one dose of carboplatin, owner elected to restage, again showing severe progression of disease. Patient was euthanized two days later.
Case log #:25 Date: 05/21/13 Patient ID: Strider
Species/Breed: canine/goldendoodle Age: 7yr. Sex: MN Wt. 33.4 kg/73.48lb/1.03m2
Diagnosis: lymphoma, azotemia, elevated liver enzymes
Advanced Skills & Procedures I performed: patient presented for tech appt. TPR (T: 100.9°F, P: 120Bpm, R: panting), obtained blood from left jugular vein for in house CBC (lymphopenia 290/uL, monocytopenia 4/uL, thrombocytopenia 189K/uL, otherwise unremarkable). Performed PE, BCS-3.5/5, quiet, ambulatory x 4- no lameness noted, mild mucoid discharge from OU, moderate dental tartar, no oral lesions noted, MM- pink, CRT- <2 seconds, no murmur/arrhythmia noted, pulses strong bilaterally. Clear respiratory sounds bilaterally, abdominal palpation soft, non-painful, no organomegaly noted, rectal exam reveal soft stool, peripheral lymph nodes: right prescapular 2cm, left prescapular 2.8x3.0x1.3cm, left popliteal 2.0x2.0x1.8cm, rest of lymph nodes within normal limits, normal gait/mentation. Calculated doses for mechlorethamine (Mustargen®, 1mg/ml, 3.0mg/m2, 3.09mg/3.09ml), and vincristine (1mg/ml, 0.7mg/m2, 0.72mg/0.72ml).
Advanced Skills & Procedures I assisted with: held patient for administration of mechlorethamine and vincristine.
Outcome: patient was euthanized 7/7/13, 3 weeks short of one year since diagnosis of T-cell, hypercalcemic lymphoma.
Species/Breed: canine/golden retriever Age: 9yr. Sex: FS Wt. 26.0 kg/57.2lb/0.88 m2
Diagnosis: splenic hemangiosarcoma stage 2
Advanced Skills & Procedures I performed: collected blood from left jugular vein for in house CBC/chemistry (HCT 28.9%, thrombocytosis 760,000). Using ultrasound guidance collected urine via cystocentesis for sterile urinalysis. Aseptically prepped skin and placed 22 gauge peripheral IV catheter in right cephalic vein. Administered dexrazoxane (Zinecard® 100mg/ml, 300mg/m2= 264mg/26.4ml) diluted with equal amount 0.9%NaCl, over 10 minutes. Dexrazoxane (Zinecard®) was used for this patient because post operatively (after splenectomy) she struggled with arrhythmia, and because of recommendation of cardiologist. Using the class II laminar safety hood, Phaseal® system, and full PPE (gown, gloves, goggles, mask) - drew up and attached extension set to t-port and then administered dolasetron (20mg/ml, 0.6mg/kg: 15.6mg/0.78ml) IV, followed by doxorubicin (2mg/ml, 30 mg/m2=26.4mg/13.2ml) diluted with 14ml of 0.9% NaCl in a 35ml syringe over 27 minutes, using PhaSeal® attachments. After chemotherapy transfusion finished flushed line with 15mls of 0.9% NaCl and removed IV catheter. Placed bandage over injection site. Filled out patient’s flow sheet and recorded charges.
Advanced Skills & Procedures I assisted with: calculated dolasetron, dexrazoxone, doxorubicin, mediation refills (maropitant, metronidazole)
Outcome: patient had two doses of dexrazoxone/doxorubicin chemotherapy and restaged via ultrasound. Liver nodules seen, but owner elected not to aspirate, but to continue with carboplatin chemotherapy. After one dose of carboplatin, owner elected to restage, again showing severe progression of disease. Patient was euthanized two days later.
Case log #:25 Date: 05/21/13 Patient ID: Strider
Species/Breed: canine/goldendoodle Age: 7yr. Sex: MN Wt. 33.4 kg/73.48lb/1.03m2
Diagnosis: lymphoma, azotemia, elevated liver enzymes
Advanced Skills & Procedures I performed: patient presented for tech appt. TPR (T: 100.9°F, P: 120Bpm, R: panting), obtained blood from left jugular vein for in house CBC (lymphopenia 290/uL, monocytopenia 4/uL, thrombocytopenia 189K/uL, otherwise unremarkable). Performed PE, BCS-3.5/5, quiet, ambulatory x 4- no lameness noted, mild mucoid discharge from OU, moderate dental tartar, no oral lesions noted, MM- pink, CRT- <2 seconds, no murmur/arrhythmia noted, pulses strong bilaterally. Clear respiratory sounds bilaterally, abdominal palpation soft, non-painful, no organomegaly noted, rectal exam reveal soft stool, peripheral lymph nodes: right prescapular 2cm, left prescapular 2.8x3.0x1.3cm, left popliteal 2.0x2.0x1.8cm, rest of lymph nodes within normal limits, normal gait/mentation. Calculated doses for mechlorethamine (Mustargen®, 1mg/ml, 3.0mg/m2, 3.09mg/3.09ml), and vincristine (1mg/ml, 0.7mg/m2, 0.72mg/0.72ml).
Advanced Skills & Procedures I assisted with: held patient for administration of mechlorethamine and vincristine.
Outcome: patient was euthanized 7/7/13, 3 weeks short of one year since diagnosis of T-cell, hypercalcemic lymphoma.